Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Alexander Paliege's publication output changed over time?
ScholarIQpublication output · 2001–2023
Output grew100% over the shown period — from 1 works in 2001 to 2 in 2023.
1
1
1
1
1
1
1
1
1
2
2001200320072009201120182019202120222023
What are the most-cited papers on Alexander Paliege?
ScholarIQmost cited works
Mediation of tubuloglomerular feedback by adenosine: Evidence from mice lacking adenosine 1 receptors
Daqing Sun, Linda C. Samuelson, Tianxin Yang, Yuning Huang, Alexander Paliege, Thomas L. Saunders, Josie Briggs, Jürgen Schnermann
Proceedings of the National Academy of Sciences. 2001407 CitationsOPEN ACCESS
The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension
Ewout J. Hoorn, Stephen B. Walsh, James A. McCormick, Antje Fürstenberg, Chao-Ling Yang, Tom Roeschel, Alexander Paliege, Alexander J. Howie, James Conley, Sebastian Bachmann, Robert J. Unwin, David H. Ellison
Nature Medicine. 2011382 Citations
Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine
Julian Stumpf, Torsten Siepmann, Tom H. Lindner, Claudia Karger, Jörg Schwöbel, Leona Anders, Robert Faulhaber‐Walter, J.-C. Schewe, Heike Martin, Holger Schirutschke, Kerstin Barnett, Jan Hüther, Petra Müller, Torsten Langer, Thilo Pluntke, Kirsten Anding‐Rost, Frank Meistring, Thomas Stehr, Annegret Pietzonka, Katja Escher, Simon Cerny, H. Rothe, Frank Pistrosch, Harald Seidel, Alexander Paliege, Joachim Beige, Ingolf Bast, Anne Steglich, Florian Gembardt, Friederike Kessel, Hannah Kröger, Patrick Arndt, Jan Sradnick, Kerstin Frank, Anna Klimová, René Mauer, Xina Grählert, Moritz Anft, Arturo Blazquez‐Navarro, Timm H. Westhoff, Ulrik Stervbo, Torsten Tonn, Nina Babel, Christian Hugo
The Lancet Regional Health - Europe. 2021309 CitationsOPEN ACCESS
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
Richard Lafayette, Jens Kristensen, Andrew Stone, Jürgen Floege, Vladimı́r Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Heather N. Reich, Brad H. Rovin, Jonathan Barratt
The Lancet. 2023308 CitationsOPEN ACCESS
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
Jonathan Barratt, Richard Lafayette, Jens Kristensen, Andrew Stone, Daniel Cattran, Jürgen Floege, Vladimı́r Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Brad H. Rovin, Guillermo Fragale, Alejandra Karl, Patricia Losisolo, Hernán Trimarchi, Ivan Gonzalez Hoyos, Mauro Lampo, Matías Monkowski, Jorge de la Fuente, Magdalena Alvarez, Daniela Stoppa, Carlos Chiurchiu, P. Novoa, Marcelo Orías, Maria Belen Barron, Ana Paula Giotto, M. Arriola, Evelin Cassini, Rafaël Maldonado, Maria Paula Dionisi, Jessica Ryan, Nigel D. Toussaint, Grant Luxton, Chen Au Peh, Vicki Levidiotis, Ross S. Francis, Richard Phoon, Elena Fedosiuk, D.M. Toropilov Toropilov, R. E. Yakubtsevich, Elena Mikhailova, Christophe Bovy, Nathalie Demoulin, Jean‐Michel Hougardy, Bart Maes, Marijn M. Speeckaert, Louis‐Philippe Laurin, Sean Barbour, Mélanie Masse, Michelle Hladunewich, Heather N. Reich, Serge Cournoyer, Karthik Tennankore, Sean Barbour, Jicheng Lv, Zhangsuo Liu, Caili Wang, Shaomei Li, Qun Luo, Zhaohui Ni, Tiekun Yan, Ping Fu, Hong Cheng, Bi‐Cheng Liu, Wanhong Lu, Jianqin Wang, Qinkai Chen, D. Wang, Zuying Xiong, Menghua Chen, Yan Xu, Jiali Wei, Pearl Pai, Lianhua Chen, Jitka Řehořová, Dita Maixnerová, Roman Šafránek, Ivan Rychlík, M Hrubý, Satu Mäkelä, Kati Vääräniemi, Fernanda Ortiz, É. Alamartine, Maïté Daroux, C. Cartery, François Vrtovsnik, Jean‐Emmanuel Serre, Eleni Stamellou, Volker Vielhauer, Christian Hugo, Klemens Budde, Britta Otte, Martin Nitschke, Evangelia Ntounousi, Ioannis Boletis, Αikaterini Papagianni, Dimitrios Goumenos, Kostas Stylianou, Synodi Zermpala
Kidney International. 2022218 CitationsOPEN ACCESS
Related on ScholarIQ
University Hospital Carl Gustav Carus
Institution
Mediation of tubuloglomerular feedback by adenosine: Evidence from mice lacking adenosine 1 receptors
Paper
The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension
Paper
Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine
Paper
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
Paper
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
Paper